Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2017-08-08 | 2017-09-22 | 18567 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2022-04-08 | 2022-06-12 | 158373 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2022-07-22 | 2022-09-01 | 165335 |
| APO-TERBINAFINE | 250MG | TABLET | Resolved | 2022-10-21 | 2023-01-06 | 172347 |
| APO-TERIFLUNOMIDE | 14MG | TABLET | Resolved | 2023-10-27 | 2024-01-12 | 208385 |
| APO-TERIPARATIDE INJECTION | 250MCG | SOLUTION | Resolved | 2025-03-20 | 2025-05-02 | 253081 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2023-08-23 | 2023-10-06 | 202818 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2023-06-02 | 2023-06-23 | 193603 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2024-06-06 | 2024-09-20 | 229764 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2024-10-04 | 2025-03-21 | 239370 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2024-01-05 | 2024-02-02 | 215212 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2022-12-05 | 2023-03-09 | 177120 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2017-09-07 | 2017-11-22 | 21209 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2018-01-31 | 2018-05-16 | 37749 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-04-05 | 2021-05-03 | 136814 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2020-06-24 | 2020-10-13 | 118781 |
| APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2021-08-16 | 2021-09-07 | 144209 |
| APO-TIAPROFENIC TABLETS -300MG | 300MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19010 |
| APO-TIAPROFENIC TABLETS-200MG | 200MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 19007 |
| APO-TICAGRELOR | 60MG | TABLET | Resolved | 2024-05-31 | 2024-07-19 | 229398 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |